JPWO2023081935A5 - - Google Patents
Info
- Publication number
- JPWO2023081935A5 JPWO2023081935A5 JP2024526788A JP2024526788A JPWO2023081935A5 JP WO2023081935 A5 JPWO2023081935 A5 JP WO2023081935A5 JP 2024526788 A JP2024526788 A JP 2024526788A JP 2024526788 A JP2024526788 A JP 2024526788A JP WO2023081935 A5 JPWO2023081935 A5 JP WO2023081935A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- optionally
- acid sequence
- encoding nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163277116P | 2021-11-08 | 2021-11-08 | |
| US63/277,116 | 2021-11-08 | ||
| PCT/US2022/079505 WO2023081935A2 (en) | 2021-11-08 | 2022-11-08 | Self-amplifying rna compositions and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542126A JP2024542126A (ja) | 2024-11-13 |
| JP2024542126A5 JP2024542126A5 (https=) | 2025-11-17 |
| JPWO2023081935A5 true JPWO2023081935A5 (https=) | 2025-11-17 |
Family
ID=86242092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526788A Pending JP2024542126A (ja) | 2021-11-08 | 2022-11-08 | 自己増幅ｒｎａ組成物及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250108105A1 (https=) |
| EP (1) | EP4430200A4 (https=) |
| JP (1) | JP2024542126A (https=) |
| KR (1) | KR20240099240A (https=) |
| CN (1) | CN118382701A (https=) |
| AU (1) | AU2022380858A1 (https=) |
| CA (1) | CA3236959A1 (https=) |
| IL (1) | IL312557A (https=) |
| WO (1) | WO2023081935A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3236959A1 (en) * | 2021-11-08 | 2023-05-11 | Sue-Jean HONG | Self-amplifying rna compositions and methods of use thereof |
| CN120082547B (zh) * | 2025-05-06 | 2025-10-03 | 北京悦康科创医药科技股份有限公司 | 用于自复制mRNA的加帽类似物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2943221A1 (en) * | 2013-01-10 | 2015-11-18 | Novartis AG | Influenza virus immunogenic compositions and uses thereof |
| BR112018069417A2 (pt) * | 2016-04-22 | 2019-01-22 | Biontech Rna Pharmaceuticals Gmbh | método para fornecer rna fita simples e ssrna |
| US10967057B2 (en) * | 2016-06-02 | 2021-04-06 | Glaxosmithkline Biologicals S.A. | Zika viral antigen constructs |
| WO2021216776A2 (en) * | 2020-04-21 | 2021-10-28 | Gritstone Bio, Inc. | Capping compounds, compositions and methods of use thereof |
| CA3236959A1 (en) * | 2021-11-08 | 2023-05-11 | Sue-Jean HONG | Self-amplifying rna compositions and methods of use thereof |
-
2022
- 2022-11-08 CA CA3236959A patent/CA3236959A1/en active Pending
- 2022-11-08 KR KR1020247014440A patent/KR20240099240A/ko active Pending
- 2022-11-08 CN CN202280074018.9A patent/CN118382701A/zh active Pending
- 2022-11-08 JP JP2024526788A patent/JP2024542126A/ja active Pending
- 2022-11-08 AU AU2022380858A patent/AU2022380858A1/en active Pending
- 2022-11-08 IL IL312557A patent/IL312557A/en unknown
- 2022-11-08 WO PCT/US2022/079505 patent/WO2023081935A2/en not_active Ceased
- 2022-11-08 EP EP22891166.5A patent/EP4430200A4/en active Pending
-
2024
- 2024-05-08 US US18/658,604 patent/US20250108105A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240209379A1 (en) | Compositions and methods for enhancing gene expression | |
| JP2021525076A5 (https=) | ||
| EP2305299B1 (en) | Chimeric alphavirus replicon particles | |
| JPWO2019226941A5 (https=) | ||
| US20190224299A1 (en) | Induce and enhance immune responses using recombinant replicon systems | |
| JP2023520354A (ja) | コロナウイルスワクチン | |
| EP4289956A1 (en) | Cis-replicon construct | |
| WO2020002525A1 (en) | Novel lassa virus rna molecules and compositions for vaccination | |
| TWI769467B (zh) | 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途 | |
| JP2005515755A5 (https=) | ||
| JP2010057496A (ja) | キメラフラビウイルスワクチン | |
| WO2022133230A1 (en) | Combination therapy for treating hepatitis b virus infection | |
| JPWO2021236854A5 (https=) | ||
| JPWO2020097393A5 (https=) | ||
| JPWO2022032196A5 (https=) | ||
| JPWO2021216776A5 (https=) | ||
| JPWO2023081935A5 (https=) | ||
| JPWO2021003348A5 (https=) | ||
| EP1029069B1 (en) | Alphavirus vectors | |
| JPWO2021203104A5 (https=) | ||
| JPWO2021216775A5 (https=) | ||
| Balsitis et al. | Alphavirus Particle-Based Vaccine Vectors | |
| HK1155984A (en) | Chimeric alphavirus replicon particles |